Website & contact details
- Group website
- The site of this company’s group or brand.
Glaxosmithkline Research & Development Limited
- Incorporated
- 22 January 1965 (61 years)
- Industry
- Other research and experimental development on natural sciences and engineering (72190)
- Directors
- Kaivan Khavandi
- Owned by
- Accounts type
- Full
- Region
- Greater London
- Address
- 79 New Oxford StreetLondonWC1A 1DG
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 4 May 2027
- Last conf. stmt
- 20 April 2026
Charges
- Total
- 1
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 1
Officers 8 active
Officer details are public data from the Companies House register.
Director · Appointed 20 August 2024
Irish
Born February 1964 (62)
Director · Appointed 25 June 2024
Turkish
Born October 1971 (55)
Khavandi, Kaivan, Dr
Director · Appointed 22 May 2024
British
Born April 1985 (41)
Pickering, Christopher David George
Director · Appointed 22 May 2024
British
Born March 1973 (53)
Director · Appointed 20 September 2023
British
Born May 1971 (55)
Whyte, Victoria
Secretary · Appointed 28 February 2011
British
Corporate Director · Appointed 31 January 2001
Corporate Director · Appointed 31 January 2001
Officer history (30 former)
20 August 2024
25 June 2024
25 June 2024
22 May 2024
Appointed Pickering, Christopher David George as Director
22 May 2024
Appointed Khavandi, Kaivan, Dr as Director
30 April 2024
Resigned Allen, David George as Director
20 September 2023
20 September 2023
1 March 2023
1 March 2023
26 February 2021
12 April 2018
29 January 2016
1 December 2015
Appointed Allen, David George as Director
2 September 2015
1 August 2015
18 February 2013
Resigned Baker, Darrell as Director
13 February 2013
28 February 2011
28 February 2011
Appointed Whyte, Victoria as Secretary
1 July 2010
Appointed Baker, Darrell as Director
30 June 2010
1 December 2002
19 March 2001
31 January 2001
Resigned Martindale, Lucy Gene as Director
31 January 2001
31 January 2001
31 January 2001
1 March 1999
Appointed Martindale, Lucy Gene as Director
1 March 1999
8 April 1998
8 April 1998
15 August 1997
15 August 1997
1 November 1995
31 October 1995
31 July 1995
Resigned Hurt, Douglas Malcolm as Director
27 July 1995
27 July 1995
30 January 1995
Resigned Feczko, Joseph Michael, Dr as Director
30 January 1995
26 January 1995
19 January 1995
19 January 1995
19 January 1995
17 January 1995
16 January 1995
16 January 1995
8 December 1994
8 December 1994
1 December 1994
1 August 1994
31 July 1994
16 February 1994
16 February 1994
1 December 1993
1 December 1993
24 May 1993
8 February 1993
Appointed Hurt, Douglas Malcolm as Director
31 December 1992
Resigned Brittain, Roy Thomas, Dr as Director
5 November 1992
Appointed Feczko, Joseph Michael, Dr as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 305979
Holdings 1
Companies where Glaxosmithkline Research & Development Limited is registered as a person with significant control
Holds 25–50% of voting rights
Active
Filings 240
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 10 August 2026 | Full accounts | 31 December 2025 | ||
| 20 April 2026 | Confirmation statement with no updates | 20 April 2026 | ||
| 14 August 2025 | Full accounts | 31 December 2024 | ||
| 30 July 2025 | Confirmation statement with no updates | 30 July 2025 | ||
| 24 September 2024 | Secretary's details changed |
Some other companies at this address
Other companies in this industry
Cambridge
Winchester
Chertsey
Leeds
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →